Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

United Therapeutics Corporation To Announce Fourth Quarter And Annual 2012 Financial Results Before Market Open On Tuesday,



  United Therapeutics Corporation To Announce Fourth Quarter And Annual 2012
      Financial Results Before Market Open On Tuesday, February 26, 2013

PR Newswire

SILVER SPRING, Md., Feb. 19, 2013

SILVER SPRING, Md., Feb. 19, 2013 /PRNewswire/ -- United Therapeutics
Corporation (NASDAQ: UTHR) announced today that it will release its fourth
quarter and annual 2012 financial results before market open on Tuesday,
February 26, 2013.

United Therapeutics will host a half-hour teleconference on Tuesday, February
26, 2013, at 9:00 a.m. Eastern Time.  The teleconference is accessible by
dialing 1-877-351-5881, with international callers dialing 1-970-315-0533.  A
rebroadcast of the teleconference will be available for one week and can be
accessed by dialing 1-855-859-2056, with international callers dialing
1-404-537-3406, and using conference code: 89593584.

This teleconference is also being webcast and can be accessed via United
Therapeutics' website at http://ir.unither.com/events.cfm.  [uthr-g]

United Therapeutics Corporation is a biotechnology company focused on the
development and commercialization of unique medicinal products.

SOURCE United Therapeutics Corporation

Website: http://www.unither.com
Contact: Andrew Fisher, +1-202-483-7000, Afisher@unither.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement